Cargando…
Anticancer Analysis of CD44 Targeted Cyclosporine Loaded Thiolated Chitosan Nanoformulations for Sustained Release in Triple-Negative Breast Cancer
INTRODUCTION: Cyclosporine (CsA), a potent immunosuppressive chemotherapeutic medication, treats numerous cancers, particularly malignant carcinoma, acute leukemia, and triple-negative breast cancer (TNBC). METHODOLOGY: A specified polymeric nanoformulation (NF) based drug delivery technique with li...
Autor principal: | Abduh, Maisa Siddiq |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10577256/ https://www.ncbi.nlm.nih.gov/pubmed/37849642 http://dx.doi.org/10.2147/IJN.S424932 |
Ejemplares similares
-
CD44 targeted delivery of oncolytic Newcastle disease virus encapsulated in thiolated chitosan for sustained release in cervical cancer: a targeted immunotherapy approach
por: Kousar, Kousain, et al.
Publicado: (2023) -
Green synthesis of hyaluronic acid coated, thiolated chitosan nanoparticles for CD44 targeted delivery and sustained release of Cisplatin in cervical carcinoma
por: Kousar, Kousain, et al.
Publicado: (2023) -
Enhanced Anticancer Activity of Nanoformulation of Dasatinib against Triple-Negative Breast Cancer
por: Bahman, Fatemah, et al.
Publicado: (2021) -
S-Protected
Thiolated Chitosan versus Thiolated
Chitosan as Cell Adhesive Biomaterials for Tissue Engineering
por: Le-Vinh, Bao, et al.
Publicado: (2023) -
Nematicidal Properties of Chitosan Nanoformulation
por: Mouniga, R., et al.
Publicado: (2023)